- Home
- BEEM vs MRKR Comparison
BEEM vs MRKR Comparison
Compare BEEM & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEEM
- MRKR
- Stock Information
- Founded
- BEEM 2006
- MRKR N/A
- Country
- BEEM United States
- MRKR United States
- Employees
- BEEM N/A
- MRKR N/A
- Industry
- BEEM Semiconductors
- MRKR Biotechnology: Pharmaceutical Preparations
- Sector
- BEEM Technology
- MRKR Health Care
- Exchange
- BEEM Nasdaq
- MRKR Nasdaq
- Market Cap
- BEEM 23.4M
- MRKR 19.1M
- IPO Year
- BEEM N/A
- MRKR N/A
- Fundamental
- Price
- BEEM $1.73
- MRKR $1.51
- Analyst Decision
- BEEM Strong Buy
- MRKR Strong Buy
- Analyst Count
- BEEM 4
- MRKR 3
- Target Price
- BEEM $5.33
- MRKR $13.17
- AVG Volume (30 Days)
- BEEM 1.1M
- MRKR 231.4K
- Earning Date
- BEEM 08-12-2025
- MRKR 08-13-2025
- Dividend Yield
- BEEM N/A
- MRKR N/A
- EPS Growth
- BEEM N/A
- MRKR N/A
- EPS
- BEEM N/A
- MRKR N/A
- Revenue
- BEEM $41,099,000.00
- MRKR $5,696,123.00
- Revenue This Year
- BEEM N/A
- MRKR N/A
- Revenue Next Year
- BEEM $38.51
- MRKR $11.28
- P/E Ratio
- BEEM N/A
- MRKR N/A
- Revenue Growth
- BEEM N/A
- MRKR 71.53
- 52 Week Low
- BEEM $1.33
- MRKR $0.95
- 52 Week High
- BEEM $7.68
- MRKR $5.99
- Technical
- Relative Strength Index (RSI)
- BEEM 60.58
- MRKR 50.81
- Support Level
- BEEM $1.39
- MRKR $1.41
- Resistance Level
- BEEM $1.56
- MRKR $1.53
- Average True Range (ATR)
- BEEM 0.10
- MRKR 0.16
- MACD
- BEEM 0.02
- MRKR -0.03
- Stochastic Oscillator
- BEEM 81.09
- MRKR 9.43
About BEEM Beam Global
Beam Global produces sustainable technology for electric vehicle (EV) charging, outdoor media, and energy security, without the construction, disruption, and costs of grid-tied solutions. Its products are founded upon its patented EV ARC and Solar Treelines and include BeamTrak patented solar tracking, and ARC Technology energy storage, along with EV charging, outdoor media, and disaster preparedness packages. From start to finish, the company develops, patents, designs, engineers, and manufactures renewably energized products that help the environment, empower communities, and keep people moving.
About MRKR Marker Therapeutics Inc.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.